Concepedia

Xiangyu Kong

XK

Statistics

Publications

8

Citations

210

H-Index

8

Active since

2015

Affiliations

Affiliated Zhongshan Hospital of Dalian University(Current)

Xiamen University

Shanghai East Hospital

Shenyang Pharmaceutical University

Xiangyu Kong is an author at Affiliated Zhongshan Hospital of Dalian University specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2015–2024

8

Publications

8

Prognostic analysis and validation of diagnostic marker genes in patients with osteoporosis

Xing Wang, Zhiwei Pei, Ting Hao et al. · Frontiers in Immunology · 2022 · 42 citations · Full text

, , +17

Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer

Heming Li, Yangzhuangzhuang Zhu, Lu Xu et al. · Journal of Experimental & Clinical Cancer Research · 2024 · 42 citations · Full text

, , +17

Dynamic changes in protein interaction between AKAP95 and Cx43 during cell cycle progression of A549 cells

Xiaoxuan Chen, Xiangyu Kong, Wenxin Zhuang et al. · Scientific Reports · 2016 · 35 citations · Full text

, , +17

Discovery of Lipid Metabolism-Related Genes for Predicting Tumor Immune Microenvironment Status and Prognosis in Prostate Cancer

Ying Zhang, Xiangyu Kong, Shiyong Xin et al. · Journal of Oncology · 2022 · 23 citations · Full text

, , +17

Synergistic effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the development of rectal cancer.

Fengjie Qi, Yangyang Yuan, Xue-hong Zhi et al. · PubMed · 2015 · 21 citations

, , +13

1–5 of 8